HomeProductsBioactive CompoundsAnti-Infective AgentsHCVVaniprevir
Chemical structure of CAS 923590-37-8

Vaniprevir

In Stock•Starting at $1389 for 1 mg
CAS No.923590-37-8
MDL No.N/A
MFC38H55N5O9S
MW757.90
InChI KeyKUQWGLQLLVFLSM-ONAXAZCASA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mgTo Be Confirmed$1389In Stock
5 mgTo Be Confirmed$2773In Stock
10 mgTo Be Confirmed$3742In Stock
25 mgTo Be Confirmed$5565In Stock
50 mgTo Be Confirmed$7502In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.923590-37-8
Product NameVaniprevir

Associated Conditions

chronic hepatitis C virus infection·infection·hepatitis C virus infection
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture.

Cell reports • Vol. 35, Issue 7 • 2021
PMID: 33984267PMC: PMC8075848DOI: 10.1016/j.celrep.2021.109133

Combination of vaniprevir with peginterferon and ribavirin significantly increases the rate of SVR in treatment-experienced patients with chronic HCV genotype 1 infection and cirrhosis.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • Vol. 12, Issue 6 • 2014
PMID: 24120953DOI: 10.1016/j.cgh.2013.09.067

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: safety, antiviral activity, resistance, and pharmacokinetics.

Antiviral research • Vol. 99, Issue 3 • 2013
PMID: 23747481DOI: 10.1016/j.antiviral.2013.05.015

Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor.

Journal of medicinal chemistry • Vol. 53, Issue 6 • 2010
PMID: 20163176DOI: 10.1021/jm9015526

Documentation

Similar Products